Literature DB >> 30921016

Treatment of Women With Epilepsy.

Mona Sazgar.   

Abstract

PURPOSE OF REVIEW: This article provides the latest information to guide practitioners in counseling and treating women with epilepsy. RECENT
FINDINGS: There is an increasing body of literature on the multidirectional effects of sex hormones on seizure frequency and severity and of seizures altering areas of the brain involved in neuroendocrine function. Ongoing pregnancy outcome data from pregnancy registries and meta-analysis of observational studies have provided key information on the safety of using antiseizure medications during pregnancy and the risk to the fetus.
SUMMARY: In treating and counseling women with epilepsy from puberty to menopause, it is important to understand the complex interactions of sex hormones, seizures, and antiseizure medications on reproductive health and pregnancy outcomes.

Entities:  

Year:  2019        PMID: 30921016     DOI: 10.1212/CON.0000000000000713

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  4 in total

Review 1.  Contraception, fecundity, and pregnancy in women with epilepsy: an update on recent literature.

Authors:  Alexa King; Elizabeth E Gerard
Journal:  Curr Opin Neurol       Date:  2022-04-01       Impact factor: 6.283

2.  Characteristics of menstrual disorders and reproductive hormones in women with epilepsy at an Indonesian national referral hospital.

Authors:  Fitri Octaviana; Kanadi Sumapraja; Winnugroho Wiratman; Luh Ari Indrawati; Astri Budikayanti
Journal:  Front Neurol       Date:  2022-09-20       Impact factor: 4.086

3.  Safety of deep brain stimulation in pregnancy: A comprehensive review.

Authors:  Caroline King; T Maxwell Parker; Kay Roussos-Ross; Adolfo Ramirez-Zamora; John C Smulian; Michael S Okun; Joshua K Wong
Journal:  Front Hum Neurosci       Date:  2022-09-29       Impact factor: 3.473

Review 4.  Principles of Epilepsy Management for Women in Their Reproductive Years.

Authors:  Rebecca Spiegel; Heidy Merius
Journal:  Front Neurol       Date:  2020-04-28       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.